Global Allergy Diagnostics Market

The global allergy diagnostics market size was valued at USD 4.8 billion in 2021 and is expected to surpass USD 8.2 billion by 2028, expanding at a CAGR of 11.1% during the forecast period, 2021–2028. Growing environmental pollution levels across the globe and rising healthcare insurance access are driving the allergy diagnostics market.

Get Free Sample Report

An allergy is an immune system hypersensitivity condition. When a person's immune system reacts to molecules in the environment called allergens, an allergic reaction occurs. Dust mites secretion, pollen, and pet dander are allergens that damage the immune system. Food allergies, skin allergies, dust allergies, insect sting allergies, medication allergies, and mold allergies are all examples of allergies. Food allergies are caused by the ingestion of specific proteins found in foods, and they can produce symptoms such as rashes and stomach issues. Medication, immune system disorders, and infections can cause skin allergies, which emerge as itchy, red, swollen, bumpy, and scaly skin. Dust allergies are caused by dust mites, pollen, pet hair, mold, and cockroaches, and can enhance asthma symptoms. Insect sting allergies can cause pain, swelling, and redness at the sting site. An allergic reaction to certain components in medications causes drug allergy, which can produce symptoms such as skin rash, hives, itchy eyes, and facial swelling. Mold allergy is produced by microscopic fungus spores floating through the air, which can cause symptoms including watery eyes, runny nose, itchy lips, and sneezing.

Allergies can affect anyone at any age; however, young children are particularly vulnerable to allergic disorders. Red eyes, itching, swelling, a runny nose, and asthma attacks are all common allergy symptoms. The term ‘allergy diagnostics’ refers to the process of detecting the nature of an allergic condition and determining how to treat it. Skin prick, intradermal, blood, and patch tests are commonly employed tests used to diagnose allergies. More than one billion individuals worldwide suffer from allergic disorders. According to the Centers for Disease Control and Prevention (CDC) each year, over 50 million people in the US suffer from various types of allergies. Allergies are the 6th greatest cause of chronic illness in the US, according to the American College of Allergy, Asthma, and Immunology (ACAAI), and the yearly cost of allergies exceeds USD 18 billion.

According to a National Health Interview Survey (NHIS) study from 2014, in the US over 8% of children under the age of 18 had hay fever, and 10% had asthma. Respiratory allergies account for 5.4%, food allergies for 5.4%, and skin allergies for 11.6%.

Market Trends, Drivers, Restraints, and Opportunities:

• Increasing prevalence of allergy across the globe is expected to boost the market in the coming years. The number of patients with allergies is rapidly increasing, and the number is expected to grow in the future. According to the World Allergy Organization (WAO), allergy incidence would rise from 15% to 40% in every country by 2030.
• Rising environmental pollution levels is anticipated to drive the market during the forecast period.
• High exposure to environmental pollutants in cities and prevalence of allergy disorders among urban residents is expected to fuel the market. According to the WHO, more than 80% of people living in cities are exposed to air quality levels that exceed the WHO safety guidelines; while this is a global trend, its consequences are particularly severe in low-income countries' metropolitan regions.
• High cost of allergy diagnostics instruments is estimated to hinder the market during the forecast period.
• The allergy diagnostics market is projected to grow rapidly in emerging economies such as India, China, and Brazil due to the increase in the prevalence of lifestyle diseases, rising awareness of health and obesity, and improving in infrastructure in these nations.

Scope of the Report

The report on the global allergy diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Global Allergy Diagnostics Market Segment Insights

Based on products & services, the allergy diagnostics market is divided into instruments, consumables, and services. The consumables segment is expected to account for a key share of the market during the forecast period. Growing prevalence of allergies and rising need for quick testing to diagnose allergic disorders fuel the growth of the consumables segment.

Get Free Sample Report

In terms of allergens, the market is segregated into food allergens, inhaled allergens, drug allergens, and others. The inhaled allergens segment is projected to account for a considerable share of the market owing to the rising environmental pollution and increasing pollen coupled with other factors including mold, fungus, and dust.

On the basis of test type, the allergy diagnostics market is segmented into in vitro tests and in vivo tests. The vivo tests segment is anticipated to account for a significant share of the market during the forecast period. Increase in acceptance of various in vivo tests, such as skin prick tests, is driving the segment. In comparison to in vitro tests, these tests are dependable, safe, convenient, and cost-effective.

In terms of end-users, the allergy diagnostics market is segregated into hospital-based laboratories, diagnostic laboratories, academic research institutes, and others. The diagnostic laboratories segment is projected to account for a considerable share of the market during the forecast period. The demand for appropriate diagnosis from a professional increases awareness regarding the management of allergic disorders, and the availability of funds for the establishment of independent diagnostic laboratories are fueling the segment.

Get Free Sample Report

On the basis of regions, the global allergy diagnostics market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. In 2020, North America held the dominant share of the market. Increase in incidences of allergies, favorable reimbursements for allergy diagnosis, and availability of supportive activities by associations fuel the market in North America.

Segments

• Instruments
• Consumables
• Services

• Food Allergens
• Inhaled Allergens
• Drug Allergens
• Other

• In Vitro Tests
• In Vivo Tests

• Hospital-based Laboratories
• Diagnostic Laboratories
• Academic Research Institutes
• Others

• Asia Pacific
• North America
• Europe
• Latin America
• Middle East &Africa

• Thermo Fisher Scientific
• Siemens Healthcare GmbH
• Danaher
• Omega Diagnostics Group PLC
• bioMérieux India Private Limited
• Romer Labs Division Holding GmbH
• EUROIMMUN Medizinische Labordiagnostika AG
• Jubilant Pharma Holdings Inc
• NEOGEN Corporation
• Eurofins Scientific
• Minaris Medical America, Inc
• Stallergenes Greer
• R-Biopharm AG
• AESKU.GROUP GmbH
• ACON Laboratories, Inc.

Competitive Landscape

Key players in the global allergy diagnostics market are Thermo Fisher Scientific, Siemens Healthcare GmbH, Danaher., Omega Diagnostics Group PLC, bioMérieux India Private Limited, Romer Labs Division Holding GmbH, EUROIMMUN Medizinische Labordiagnostika AG, Jubilant Pharma Holdings Inc., NEOGEN Corporation., Eurofins Scientific, Minaris Medical America, Inc., Stallergenes Greer, R-Biopharm AG, AESKU.GROUP GmbH, and ACON Laboratories, Inc.